Ssion. TA muscles were given 10 twice-weekly intramuscular injections of 5 μg of ESO complexed with the NG-PEI2K(PEG550)copolymer, and harvested 6 wks after the first injection. () Images of serial whole transverse sections immunolabeled for dystrophin (A) and nNOS (B) show the correlation in ESO-mediated upregulation of these two membrane-associated proteins. Higher magnification images of specific regions from panels A and B show clearly the concomitant (co-localized) upregulation of both dystrophin and nNOS in the same set of fibers of the polyplex-injected muscles. As expected nNOS expression in untreated controls was negligible.<p><b>Copyright information:</b></p><p>Taken from "Nanopolymers improve delivery of exon skipping oligonucleo...
Duchenne muscular dystrophy (DMD) is a genetic disease caused by a mutation in the X-linked Dytrophi...
Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dyst...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Ons of either 1 μg () or 5 μg () of ESO complexed with the NG-PEI2K(PEG550)copolymer. Muscles were h...
�g of ESO per injection (3, 15, 30, and 60 μg total) and harvested 3 wks after the first injection. ...
EG550), or CG-PEI2K(PEG5K)copolymers, and harvested 3 wks after the first injection. Number of dystr...
EG550), or CG-PEI2K(PEG5K)copolymers, and harvested 3 wks after the first injection. Number of dystr...
harvested 3 wks after the first injection. Dystrophin immunolabeling (Hoechst dye counterstained) at...
harvested 3 wks after the first injection. Dystrophin immunolabeling (Hoechst dye counterstained) at...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)- med...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
Duchenne muscular dystrophy (DMD) is a severe hereditary neuromuscular disorder caused by mutations ...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Abstract Duchenne muscular dystrophy (DMD) is a severe hereditary neuromuscular disorder caused by m...
Duchenne muscular dystrophy (DMD) is a genetic disease caused by a mutation in the X-linked Dytrophi...
Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dyst...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Ons of either 1 μg () or 5 μg () of ESO complexed with the NG-PEI2K(PEG550)copolymer. Muscles were h...
�g of ESO per injection (3, 15, 30, and 60 μg total) and harvested 3 wks after the first injection. ...
EG550), or CG-PEI2K(PEG5K)copolymers, and harvested 3 wks after the first injection. Number of dystr...
EG550), or CG-PEI2K(PEG5K)copolymers, and harvested 3 wks after the first injection. Number of dystr...
harvested 3 wks after the first injection. Dystrophin immunolabeling (Hoechst dye counterstained) at...
harvested 3 wks after the first injection. Dystrophin immunolabeling (Hoechst dye counterstained) at...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)- med...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
For subsets of Duchenne muscular dystrophy (DMD) mutations, antisense oligoribonucleotide (AON)-medi...
Duchenne muscular dystrophy (DMD) is a severe hereditary neuromuscular disorder caused by mutations ...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Abstract Duchenne muscular dystrophy (DMD) is a severe hereditary neuromuscular disorder caused by m...
Duchenne muscular dystrophy (DMD) is a genetic disease caused by a mutation in the X-linked Dytrophi...
Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder caused by mutations in the dyst...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...